Literature DB >> 14654998

Early intervention in schizophrenia: three frameworks for guiding ethical inquiry.

Philip J Candilis1.   

Abstract

Psychiatric research is making important strides toward early detection and treatment of schizophrenia. Discovery of genetic markers, identifiable prodromes, and low-risk interventions fuel this vital scientific movement. At the same time, investigators and clinicians are studying the ethical questions that arise whenever the bounds of diagnosis and treatment are evolving rapidly. This ethical analysis generally falls within three dominant frameworks of bioethics: the conceptualization of disease, scientific uncertainty, and risk-factor ethics. These frameworks are explored as potential guides for directing ethical inquiry in early intervention.

Entities:  

Mesh:

Year:  2003        PMID: 14654998     DOI: 10.1007/s00213-003-1412-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

Review 1.  Ethics and early intervention in psychosis: keeping up the pace and staying in step.

Authors:  P D McGorry; A Yung; L Phillips
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

Review 2.  Preventing severe mental illnesses--new prospects and ethical challenges.

Authors:  K F Schaffner; P D McGorry
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

3.  The MacArthur Treatment Competence Study. II: Measures of abilities related to competence to consent to treatment.

Authors:  Thomas Grisso; Paul S Appelbaum; Edward P Mulvey; Kenneth Fletcher
Journal:  Law Hum Behav       Date:  1995-04

4.  The prevention of schizophrenia: what interventions are safe and effective?

Authors:  R Warner
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

5.  Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk.

Authors:  T H McGlashan; T J Miller; S W Woods
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

6.  Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation.

Authors:  L W Roberts; T D Warner; J L Brody
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

Review 7.  Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?

Authors:  T H McGlashan
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

Review 8.  Neuroleptics and the natural course of schizophrenia.

Authors:  R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

9.  Competency to give an informed consent. A model for making clinical assessments.

Authors:  J F Drane
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

Review 10.  Early detection and intervention with schizophrenia: rationale.

Authors:  T H McGlashan; J O Johannessen
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

View more
  2 in total

Review 1.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

2.  Perspectives of psychiatric investigators and IRB chairs regarding benefits of psychiatric genetics research.

Authors:  Laura Weiss Roberts; Laura B Dunn; Jane Paik Kim; Maryam Rostami
Journal:  J Psychiatr Res       Date:  2018-09-15       Impact factor: 4.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.